CCM vs DBVT vs ALKS vs RDNT

For growth investors, RadNet, Inc.

(RDNT) is the stronger pick with 11. 5% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1.

4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: RDNT returned +961. 2% versus CCM's -87. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.

51β versus RadNet, Inc. 's 1. 40β — meaning RDNT is approximately 176% more volatile than CCM relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), RadNet, Inc.

(RDNT) is pulling ahead at 11. 5% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Concord Medical Services Holdings Limited grew EPS -3. 6% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -138. 6% for CCM. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.

4x forward P/E versus 94. 4x for RadNet, Inc. — 93. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Concord Medical Services Holdings Limited (CCM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

51)). Both have compounded well over 10 years (CCM: -87. 5%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.